肝硬化首次诊断后及时随访与死亡率降低相关但对再住院无影响:一项基于人群的8852例患者队列
该研究基于瑞典国家患者登记系统,纳入2002至2020年间首次因肝硬化住院的8852例患者,评估出院后90天内门诊随访率及其与1年内再住院和死亡率的关系。42%的患者在出院后90天内接受了门诊随访,及时随访与1年内全因死亡率降低相关(aHR=0.86,95%CI=0.78-0.96),但对再住院无显著影响(aHR=0.97,95%CI=0.91-1.03)。
要点
- 肝硬化首次诊断住院患者中42%在出院后90天内接受门诊随访。
- 90天内随访与1年内全因死亡率降低相关(aHR=0.86,95%CI=0.78-0.96)。
- 90天内随访对1年内再住院无显著影响(aHR=0.97,95%CI=0.91-1.03)。
核心结论
- 在瑞典,42%的新诊断肝硬化住院患者在出院后90天内接受门诊随访,这些患者可能经历较低的死亡率但1年内再住院无变化。
研究设计与样本
- 基于人群的队列研究,从瑞典国家患者登记系统识别2002至2020年间所有住院期间诊断为肝硬化的患者,共8852例。
主要发现
- 8852例患者中3759例(42%)在出院后90天内接受了门诊随访。
- 接受90天内随访的患者较无及时随访者更年轻、教育水平更高,且更可能伴有肝失代偿或肝细胞癌。
- 90天内随访与1年内全因死亡率降低相关(aHR=0.86,95%CI=0.78-0.96)。
- 90天内随访对1年内再住院无显著影响(aHR=0.97,95%CI=0.91-1.03)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Timely transition of care amongst patients with a first diagnosis of cirrhosis in a hospital to an outpatient visit is important. We evaluated rates of outpatient follow-up after a first diagnosis of cirrhosis during an inpatient setting, and its association with subsequent rates of rehospitalisation and mortality. METHODS: We conducted a population-based cohort study identifying all hospitalised patients in Sweden diagnosed with cirrhosis between 2002 and 2020 from the Swedish National Patient Register. The primary outcome was any outpatient visit related to cirrhosis within 90 days after hospital discharge. Secondary outcomes were rates of rehospitalisation and mortality within 1 year of discharge in patients receiving outpatient follow-up within 90 days or not. Cox regression was used for all analyses, and incidence rates per 1000 person-years were calculated for mortality and rehospitalisation. RESULTS: Of 8852 patients, 3759 (42%) had outpatient follow-up within 90 days of discharge. Patients who received follow-up within 90 days of discharge were younger, had a higher level of education and were more likely to have liver decompensation or hepatocellular carcinoma compared to those without timely follow-up. We found that follow-up within 90 days was associated with lower rates of all-cause mortality within 1 year (aHR = 0.86, 95%CI = 0.78-0.96) but with no significant impact on rehospitalisations (aHR = 0.97, 95%CI = 0.91-1.03). CONCLUSIONS: In Sweden, 42% of hospitalised patients with newly diagnosed cirrhosis receive outpatient follow-up within 90 days of their hospital discharge. These patients may experience lower mortality but no change in rehospitalisations within 1 year.
引用
- Schechter MS, Widman L, Wester A, et al. Timely Follow-Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population-Based Cohort of 8852 Patients. Aliment Pharmacol Ther. 2024. PMID: 39354777. doi:10.1111/apt.18309
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。